Process and method for diagnosing Alzheimer's disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8481701
APP PUB NO 20110086776A1
SERIAL NO

12935098

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention concerns methods and compositions usable for diagnosing Alzheimer's disease in mammals, in particular humans. It particularly describes serum markers for Alzheimer's disease and their use in diagnostic methods. It also concerns tools and/or kits usable for implementing these methods (reagents, probes, primers, antibodies, chips, cells, etc.), their preparation and their use. The invention is usable to detect the presence or progression of Alzheimer's disease in mammals, including in the early phase, as well as for predicting the efficacy of an Alzheimer's disease treatment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EXONHIT THERAPEUTICS SA63-65 BLD MASSENA PARIS F-75013

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beurdeley, Pascale Fontenay Sous Bois, FR 5 6
Bracco, Laurent La Garenne Colombes, FR 20 90
Jarrige-Le, Prado Anne-Charlotte Paris, FR 1 6
Pallares, Diego Paris, FR 2 6
Rouet, Fabien Rueil Malmaison, FR 1 6

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 9, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00